γ-(6-Aminohexyl)-GTP - ATTO-740
|
|
|
Arabinosyluridine-5'-triphosphate (triethylammonium salt form)
|
|
|
7-Propargylamino-7-deaza-dGTP - 5/6-TAMRA
|
|
|
7-Propargylamino-7-deaza-ddGTP - DYQ-661
|
|
|
6-Amino-4-methoxy-2-(2,3,5-tri-O-benzoyl-b-D-ribofuranosyl)-2H-pyrazolo[3,4-d]pyrimidine
|
|
|
5-Propargylamino-CTP - ATTO-612Q
|
|
|
8-Iodo-ADP
|
|
|
EDA-GTP - ATTO-594
|
|
|
8-Azido-ADP
|
|
|
7-Propargylamino-7-deaza-dATP - ATTO-488
|
|
|
9-(2'-O-Acetyl-3',5'-di-O-benzoyl-3'-beta-C-methyl-beta-D-ribofuranosyl)-6-chloropurine
|
|
|
Aminoallyl-dUTP - ATTO-390
|
|
|
7-Propargylamino-7-deaza-dATP - ATTO-532
|
|
|
L-Turicine
|
|
174851-67-3
|
Aminoallyl-dUTP - ATTO-647N
|
|
|
NGA4 Glycan, 2-AA labelled
|
|
|
8-N3-ε-ADP
|
|
|
7-Propargylamino-7-deaza-dGTP - Cy5
|
|
|
8-[(6-Amino)hexyl]-amino-cAMP - 6-FAM
|
|
|
N1-Methyl-2'-beta-C-methylinosine
|
|
|
5-Propargylamino-ddCTP - DYQ-661
|
|
|
7-Propargylamino-7-deaza-dATP - DYQ-661
|
|
|
6-Amino-4-methoxy-1-(2-deoxy-b-D-ribofuranosyl)-1H-pyrazolo[3,4-d]pyrimidine
|
|
|
γ-[(6-Aminohexyl)imido]-dGTP - ATTO-488
|
|
|
EDA-AppNHp (EDA-AMPPNP) - 5/6-TAMRA
|
|
|
EDA-m7GDP - Cy3
|
|
|
5-Propargylamino-dCTP - ATTO-MB2
|
|
|
Aminoallyl-UTP - ATTO-594
|
|
|
5-Propargylamino-ddUTP - ATTO-655
|
|
|
dU-CPG 1000
|
|
|
8-[(6-Amino)hexyl]-amino-cGMP - DYQ-660
|
|
|
5-Propargylamino-ddCTP - ATTO-Rho101
|
|
|
N6-(6-Amino)hexyl-ATP - ATTO-532
|
|
|
5-Methoxy-5'(R)-C-methyluridine
|
|
|
7-Propargylamino-7-deaza-dGTP - ATTO-580Q
|
|
|
γ-[(6-Aminohexyl)imido]-dATP - ATTO-647N
|
|
|
EDA-ATP - Texas Red
|
|
|
8-[(6-Amino)hexyl]-amino-cAMP - ATTO-565
|
|
|
7-Propargylamino-7-deaza-ddGTP - ATTO-620
|
|
|
7-Deaza-dGDP
|
|
|
EDA-ATP - DY-751
|
|
|
8-[φ-575]-cGMP
|
|
|
Aminoallyl-dUTP - Texas Red
|
|
|
Mant-ITPγS
|
|
|
7-Propargylamino-7-deaza-dATP - ATTO-594
|
|
|
5'-O-Benzoyl-3'-O-(4-methoxybenzoyl)-2'-O,4'-C-methyleneuridine
|
|
|
Cytidine (N-iBu)
|
|
|
D-(+)-Glucurono-3,6-lactone
|
|
32449-92-6
|
EDA-ATPγS - ATTO-Rho14
|
|
|
Aminoallyl-UTP - ATTO-590
|
|
|
7-Propargylamino-7-deaza-dGTP - ATTO-540Q
|
|
|
7-Propargylamino-7-deaza-dGTP - ATTO-633
|
|
|
7-Propargylamino-7-deaza-dGTP - ATTO-700
|
|
|
N6-(6-Amino)hexyl-dATP - ATTO-655
|
|
|
γ-(6-Aminohexyl)-GTP - ATTO-390
|
|
|
5-Propargylamino-ddUTP - Cy3
|
|
|
EDA-ADP - ATTO-680
|
|
|
5-Propargylamino-ddUTP - ATTO-Rho14
|
|
|
8-[(6-Amino)hexyl]-amino-cAMP - ATTO-680
|
|
|
8-Bromo-GppNHp
|
|
|
5-Propargylamino-ddCTP - ATTO-540Q
|
|
|
N1-Methyl-2'-beta-C-methyladenosine
|
|
|
2-Deoxy-2-fluoroarabinoadenosine-3-CE-phosphoramidite
|
|
|
7-Propargylamino-7-deaza-dATP - 6-ROX
|
|
|
1-[6-(Diethoxyphosphinyl)-2-O-(2-methoxyethyl)-β-D-ribo-hexofuranosyl]uracil
|
|
|
7-Propargylamino-7-deaza-ddGTP - Cy5
|
|
|
7-Propargylamino-7-deaza-ddGTP - 5/6-TAMRA
|
|
|
EDA-GTPγS - ATTO-590
|
|
|
7-Propargylamino-7-deaza-dATP - ATTO-612Q
|
|
|
EDA-m7GDP - ATTO-580Q
|
|
|
EDA-m7GDP - ATTO-390
|
|
|
Aminoallyl-dUTP - ATTO-MB2
|
|
|
EDA-AppNHp (EDA-AMPPNP) - ATTO-Rho12
|
|
|
8-[(6-Amino)hexyl]-amino-cAMP - ATTO-Rho11
|
|
|
5-Propargylamino-ddCTP - DYQ-660
|
|
|
N6-(6-Amino)hexyl-AMP
|
|
|
Blood Group B-HSA (Globulin Free 6-Atom Spacer)
|
|
|
EDA-GTPγS - DY-480XL
|
|
|
5-Propargylamino-dCTP - ATTO-425
|
|
|
5-Propargylamino-dCTP - OYSTER-656
|
|
|
N6-(6-Amino)hexyl-dATP - ATTO-580Q
|
|
|
N6-(6-Amino)hexyl-dATP-ATTO-MB2
|
|
|
4-Amino-5-cyano-1-(2-deoxy-β-D-ribofuranosyl)-7H-pyrrolo[2,3-d]pyrimidine
|
|
|
7-Propargylamino-7-deaza-dATP - DY-751
|
|
|
5-Propargylamino-dCTP - ATTO-Thio12
|
|
|
GMPαS
|
|
|
EDA-GTPγS - DY-751
|
|
|
8-[(6-Amino)hexyl]-amino-cAMP - ATTO-550
|
|
|
N6-(6-Amino)hexyl-dATP - ATTO-Rho12
|
|
|
EDA-GTP - DY-776
|
|
|
3'-Deoxy-3'-fluoro-N6-(p-methoxybenzyl)adenosine
|
|
|
Aminoallyl-dUTP - ATTO-580Q
|
|
|
Lewisx trisaccharide-BSA (3 atom spacer)
|
|
|
5-Propargylamino-ddUTP - Texas Red
|
|
|
EDA-AppNHp (EDA-AMPPNP) - ATTO-540Q
|
|
|
5-Propargylamino-CTP - ATTO-465
|
|
|
EDA-ATPγS - ATTO-Rho12
|
|
|
γ-[(6-Aminohexyl)-imido]-ATP-Biotin
|
|
|
EDA-m7GTP - ATTO-Rho12
|
|
|
EDA-m7GDP - ATTO-655
|
|
|